Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Osteoporosis | Research

Bone mineral density in lower thoracic vertebra for osteoporosis diagnosis in older adults during CT lung cancer screening

Authors: Nandong Hu, Miaomiao Wang, Meng Yang, Xin Chen, Jiangchuan Wang, Chao Xie, Bin Zhang, Zhongqiu Wang, Xiao Chen

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

Quantitative computed tomography (QCT)-based lumbar bone mineral density (LBMD) has been used to diagnose osteoporosis. This study explored the value of lower thoracic BMD (TBMD) in diagnosing osteoporosis in older adults during CT lung cancer screening.

Methods

This study included 751 subjects who underwent QCT scans with both LBMD and TBMD. 141 of them was selected for a validation. Osteoporosis was diagnosed based on LBMD using the ACR criteria (gold standard). TBMD thresholds were obtained using receiver operating characteristic curve. TBMD was also translated into LBMD (TTBMD) and osteoporosis was defined based on TTBMD using ACR criteria. The performance of TBMD and TTBMD in identifying osteoporosis was determined by Kappa test. The associations between TBMD- and TTBMD-based osteoporosis and fracture were tested in 227 subjects with followed up status of spine fracture.

Results

The performance of TBMD in identifying osteoporosis was low (kappa = 0.66) if using the ACR criteria. Two thresholds of TBMD for identifying osteopenia (128 mg/cm3) and osteoporosis (91 mg/cm3) were obtained with areas under the curve of 0.97 and 0.99, respectively. The performance of the identification of osteoporosis/osteopenia using the two thresholds or TTBMD both had good agreement with the gold standard (kappa = 0.78, 0.86). Similar results were observed in validation population. Osteoporosis identified using the thresholds (adjusted hazard ratio (HR) = 18.72, 95% confidence interval (CI): 5.13–68.36) or TTBMD (adjusted HR = 10.28, 95% CI: 4.22–25.08) were also associated with fractures.

Conclusion

Calculating the threshold of TBMD or normalizing TBMD to LBMD are both useful in identifying osteoporosis in older adults during CT lung cancer screening.
Appendix
Available only for authorised users
Literature
2.
go back to reference Mazzone PJ, Silvestri GA, Souter LH, Caverly TJ, Kanne JP, Katki HA, Wiener RS, Detterbeck FC. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2021;160(5):e427–94.CrossRefPubMedPubMedCentral Mazzone PJ, Silvestri GA, Souter LH, Caverly TJ, Kanne JP, Katki HA, Wiener RS, Detterbeck FC. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2021;160(5):e427–94.CrossRefPubMedPubMedCentral
3.
go back to reference Jang S, Graffy PM, Ziemlewicz TJ, et al. Opportunistic osteoporosis screening at routine abdominal and thoracic CT: normative L1 trabecular attenuation values in more than 20 000 adults. Radiology. 2019;291(2):360–7.CrossRefPubMed Jang S, Graffy PM, Ziemlewicz TJ, et al. Opportunistic osteoporosis screening at routine abdominal and thoracic CT: normative L1 trabecular attenuation values in more than 20 000 adults. Radiology. 2019;291(2):360–7.CrossRefPubMed
4.
go back to reference Cheng X, Zhao K, Zha X et al. Opportunistic screening using low-dose CT and the prevalence of osteoporosis in China: a Nationwide, Multicenter Study. J Bone Miner Res. Cheng X, Zhao K, Zha X et al. Opportunistic screening using low-dose CT and the prevalence of osteoporosis in China: a Nationwide, Multicenter Study. J Bone Miner Res.
5.
go back to reference Therkildsen J, Nissen L, Jorgensen HS, Thygesen J, Ivarsen P, Frost L. Thoracic bone Mineral Density Derived from Cardiac CT is Associated with Greater Fracture Rate. Volume 296. Radiology; 2020. pp. 499–508. 3. Therkildsen J, Nissen L, Jorgensen HS, Thygesen J, Ivarsen P, Frost L. Thoracic bone Mineral Density Derived from Cardiac CT is Associated with Greater Fracture Rate. Volume 296. Radiology; 2020. pp. 499–508. 3.
6.
go back to reference Budoff MJ, Khairallah W, Li D, et al. Trabecular bone mineral density measurement using thoracic and lumbar quantitative computed tomography. Acad Radiol. 2012;19(2):179–83.CrossRefPubMed Budoff MJ, Khairallah W, Li D, et al. Trabecular bone mineral density measurement using thoracic and lumbar quantitative computed tomography. Acad Radiol. 2012;19(2):179–83.CrossRefPubMed
7.
go back to reference Budoff MJ, Hamirani YS, Gao YL, et al. Measurement of thoracic bone mineral density with quantitative CT. Radiology. 2010;257(2):434–40.CrossRefPubMed Budoff MJ, Hamirani YS, Gao YL, et al. Measurement of thoracic bone mineral density with quantitative CT. Radiology. 2010;257(2):434–40.CrossRefPubMed
8.
go back to reference Rühling S, Scharr A, Sollmann N, et al. Proposed diagnostic volumetric bone mineral density thresholds for osteoporosis and osteopenia at the cervicothoracic spine in correlation to the lumbar spine. Eur Radiol. 2022;32(9):6207–14.CrossRefPubMedPubMedCentral Rühling S, Scharr A, Sollmann N, et al. Proposed diagnostic volumetric bone mineral density thresholds for osteoporosis and osteopenia at the cervicothoracic spine in correlation to the lumbar spine. Eur Radiol. 2022;32(9):6207–14.CrossRefPubMedPubMedCentral
9.
go back to reference Cheng X, Wang L, Zeng Q, Wu J. The China guideline for the diagnosis criteria of osteoporosis with quantitative computed tomography (QCT) (2018). J Chin Osteop. 2019;25(6):733–7. Cheng X, Wang L, Zeng Q, Wu J. The China guideline for the diagnosis criteria of osteoporosis with quantitative computed tomography (QCT) (2018). J Chin Osteop. 2019;25(6):733–7.
10.
go back to reference Salzmann SN, Okano I, Jones C, et al. Preoperative MRI-based vertebral bone quality (VBQ) score assessment in patients undergoing lumbar spinal fusion. Spine J. 2022;22(8):1301–8.CrossRefPubMed Salzmann SN, Okano I, Jones C, et al. Preoperative MRI-based vertebral bone quality (VBQ) score assessment in patients undergoing lumbar spinal fusion. Spine J. 2022;22(8):1301–8.CrossRefPubMed
11.
go back to reference Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434–41.CrossRefPubMed Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434–41.CrossRefPubMed
13.
go back to reference Johannesdottir F, Allaire B, Kopperdahl DL, et al. Bone density and strength from thoracic and lumbar CT scans both predict incident vertebral fractures independently of fracture location. Osteoporos Int. 2021;32(2):261–69.CrossRefPubMed Johannesdottir F, Allaire B, Kopperdahl DL, et al. Bone density and strength from thoracic and lumbar CT scans both predict incident vertebral fractures independently of fracture location. Osteoporos Int. 2021;32(2):261–69.CrossRefPubMed
14.
go back to reference Harrison JE, Patt N, Müller C, Bayley TA, Budden FH, Josse RG, Murray TM, Sturtridge WC, Strauss A, Goodwin S. Bone mineral mass associated with postmenopausal vertebral deformities. Bone Min. 1990;10(3):243–51.CrossRef Harrison JE, Patt N, Müller C, Bayley TA, Budden FH, Josse RG, Murray TM, Sturtridge WC, Strauss A, Goodwin S. Bone mineral mass associated with postmenopausal vertebral deformities. Bone Min. 1990;10(3):243–51.CrossRef
16.
go back to reference Hong C, Choi S, Park M, et al. Body composition and osteoporotic fracture using an thropometric prediction equations to assess muscle and fat masses. J Cachexia Sarcopenia Muscle. 2021;12(6):2247–58.CrossRefPubMedPubMedCentral Hong C, Choi S, Park M, et al. Body composition and osteoporotic fracture using an thropometric prediction equations to assess muscle and fat masses. J Cachexia Sarcopenia Muscle. 2021;12(6):2247–58.CrossRefPubMedPubMedCentral
17.
go back to reference Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34(1):195–202.CrossRefPubMed Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34(1):195–202.CrossRefPubMed
18.
go back to reference Odén A, McCloskey EV, Johansson H, et al. Assessing the impact of osteoporosis on the burden of hip fractures. Calcif Tissue Int. 2013;92(1):42–9.CrossRefPubMed Odén A, McCloskey EV, Johansson H, et al. Assessing the impact of osteoporosis on the burden of hip fractures. Calcif Tissue Int. 2013;92(1):42–9.CrossRefPubMed
19.
go back to reference Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330–8.CrossRefPubMed Moyer VA, U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330–8.CrossRefPubMed
20.
go back to reference Yang G, Wang Y, Wu Y, et al. The road to effective tobacco control in China. Lancet. 2015;385(9972):1019–28.CrossRefPubMed Yang G, Wang Y, Wu Y, et al. The road to effective tobacco control in China. Lancet. 2015;385(9972):1019–28.CrossRefPubMed
21.
go back to reference Hao J, Li N, Chen W. China Guideline for the screening and early detection of Lung Cancer (2021 Beijing). Zhonghua Zhong Liu Za Zhi. 2021;43(3):243–68. Hao J, Li N, Chen W. China Guideline for the screening and early detection of Lung Cancer (2021 Beijing). Zhonghua Zhong Liu Za Zhi. 2021;43(3):243–68.
22.
go back to reference Luo X, Zheng S, Liu Q, et al. Should nonsmokers be excluded from early lung cancer screening with low-dose spiral computed tomography? Community-based practice in Shanghai. Transl Oncol. 2017;10(4):485–90.CrossRefPubMedPubMedCentral Luo X, Zheng S, Liu Q, et al. Should nonsmokers be excluded from early lung cancer screening with low-dose spiral computed tomography? Community-based practice in Shanghai. Transl Oncol. 2017;10(4):485–90.CrossRefPubMedPubMedCentral
23.
go back to reference Therkildsen J, Winther S, Nissen L, et al. Feasibility of opportunistic screening for low thoracic bone Mineral density in patients referred for routine cardiac CT. J Clin Densitom. 2020;23(1):117–27.CrossRefPubMed Therkildsen J, Winther S, Nissen L, et al. Feasibility of opportunistic screening for low thoracic bone Mineral density in patients referred for routine cardiac CT. J Clin Densitom. 2020;23(1):117–27.CrossRefPubMed
24.
go back to reference Salzmann SN, Okano I, Jones C, et al. Thoracic bone mineral density measured by quantitative computed tomography in patients undergoing spine surgery. Spine J. 2021;21(11):1866–72.CrossRefPubMed Salzmann SN, Okano I, Jones C, et al. Thoracic bone mineral density measured by quantitative computed tomography in patients undergoing spine surgery. Spine J. 2021;21(11):1866–72.CrossRefPubMed
Metadata
Title
Bone mineral density in lower thoracic vertebra for osteoporosis diagnosis in older adults during CT lung cancer screening
Authors
Nandong Hu
Miaomiao Wang
Meng Yang
Xin Chen
Jiangchuan Wang
Chao Xie
Bin Zhang
Zhongqiu Wang
Xiao Chen
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04737-4

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine